Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-SIP23-001, Effective Community Conversations for Influenza and COVID-19 Vaccine Uptake; Amended Notice of Closed Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

March 10, 2023

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 47 (Friday, March 10, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 47 (Friday, March 10, 2023)]
[Notices]
[Page 15032]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-04918]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)-SIP23-001, Effective Community Conversations for 
Influenza and COVID-19 Vaccine Uptake; Amended Notice of Closed Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)-SIP23-001, Effective Community Conversations for Influenza and 
COVID-19 Vaccine Uptake; May 2, 2023, 11:00 a.m.-3:00 p.m., EDT, 
teleconference, in the original Federal Register Notice. The meeting 
was published in the Federal Register on February 13, 2023, Volume 88, 
Number 29, page 9289.
    The meeting is being amended to change the meeting time and should 
read as follows:

Date: May 2, 2023
Time: 10 a.m.-6 p.m., EDT

    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Catherine Barrett, Ph.D., Scientific 
Review Officer, National Center for Chronic Disease Prevention and 
Health Promotion, CDC, 4770 Buford Highway, Mailstop S107-3, Atlanta, 
Georgia 30341-3717; Telephone: (770) 718-7664; Email: <a href="/cdn-cgi/l/email-protection#6724250615150213132704030449000811"><span class="__cf_email__" data-cfemail="88cbcae9fafaedfcfcc8ebeceba6efe7fe">[email&#160;protected]</span></a>.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04918 Filed 3-9-23; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on March 10, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.